Director/PDMR and PCA Shareholding

RNS Number : 0989N

Advanced Medical Solutions Grp PLC

03 May 2018

 

3 May 2018

            Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

            Director/PDMR and PCA Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, announces that it was notified on 30 April 2018 that Simon Coates, who is a PDMR, following the successful achievement of certain performance criteria, had on 30 April 2018 exercised and sold 28,193 options from the Long Term Incentive Plan (LTIP). His beneficial ownership remains unchanged.

The Company further announces that it was notified on 30 April 2018 that Jeff Willis, who is a PDMR, following the successful achievement of certain performance criteria, had on 30 April 2018 exercised and sold 40,350 options from the Long Term Incentive Plan (LTIP). His beneficial ownership remains unchanged.

Long Term Incentive Plan (LTIP)

PDMR	No. of LTIPs prior to exercise	LTIPs exercised	Ordinary Shares sold	Ordinary shares retained	LTIPs after exercise
Simon Coates PDMR	84,275	28,193	28,193	Nil	56,082
Jeff Willis PDMR	156,678	40,350	40,350	Nil	116,328

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name: Simon Coates
2.	Reason for the notification
a)	Position/status: PDMR
b)	Initial notification/Amendment: Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name:   Advanced Medical Solutions Group plc
b)	LEI: 213800HJP6OWOSZI1L74
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594
b)	Nature of the transactions: ·        Exercise of 28,193 shares from the Long Term Incentive Plan ·        Sale of 28,193 Ordinary Shares of 5p
c)	Price(s) and volume(s): Sale of shares: Price(s) Volume(s) £3.0677 28,193
d)	Aggregated information: (Relates to those shares sold only) Aggregated volume: 28,193 Aggregated price: £3.0677
e)	Date of the transaction: 30/04/2018
f)	Place of the transaction: London Stock Exchange, AIM Market (XLON)

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name: Jeff Willis
2.	Reason for the notification
a)	Position/status: PDMR
b)	Initial notification/Amendment: Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name:   Advanced Medical Solutions Group plc
b)	LEI: 213800HJP6OWOSZI1L74
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument: Ordinary Shares of 5p Identification code: GB0004536594
b)	Nature of the transactions: ·        Exercise of 40,350 shares from the Long Term Incentive Plan ·        Sale of 40,350 Ordinary Shares of 5p
c)	Price(s) and volume(s): Sale of shares: Price(s) Volume(s) £3.0677 40,350
d)	Aggregated information: (Relates to those shares sold only) Aggregated volume: 40,350 Aggregated price: £3.0677
e)	Date of the transaction: 30/04/2018
f)	Place of the transaction: London Stock Exchange, AIM Market (XLON)

- End -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc	Tel: [phone]
Chris Meredith, Chief Executive Officer Mary Tavener, Chief Financial Officer
Consilium Strategic Communications	Tel: [phone]
Mary-Jane Elliott / Matthew Neal / Philippa Gardner	[e-mail]
Investec Bank PLC (NOMAD & Broker)	Tel: [phone]
Daniel Adams / Patrick Robb / Gary Clarence

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal^®, LiquiBand^® and RESORBA^® as well as supplying under white label.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 75 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Group has approximately 600 employees. For more information, please see www.admedsol.com.

 

END

 

 

DSHLLFFDERIVIIT